CAI Ying,QIAN Li,WANG Kailiang,et al.Mechanism of ginkgo flavonoid aglycone against doxorubicin-induced cardiotoxicity[J].ZHONGGUO YAOFANG,2024,35(06):659-664.
CAI Ying,QIAN Li,WANG Kailiang,et al.Mechanism of ginkgo flavonoid aglycone against doxorubicin-induced cardiotoxicity[J].ZHONGGUO YAOFANG,2024,35(06):659-664. DOI: 10.6039/j.issn.1001-0408.2024.06.04.
Mechanism of ginkgo flavonoid aglycone against doxorubicin-induced cardiotoxicity
To investigate the potential mechanism of the effect of ginkgo flavone aglycone (GA) against doxorubicin (DOX)-induced cardiotoxicity.
METHODS
2
The male ICR mice were randomized into control group (CON group), model group (DOX group) and GA+DOX group (GDOX group), with 12 mice in each group. The DOX group was injected with DOX solution at a dose of 3 mg/kg via tail vein every other day, and the GDOX group was given GA suspension intragastrically at a dose of 100 mg/kg every day+DOX solution at a dose of 3 mg/kg via tail vein every other day, for 15 consecutive days. After the end of administration, the serum levels of aspartate aminotransferase(AST), creatine kinase(CK), creatine kinase isoenzyme(CK-MB) and lactate dehydrogenase(LDH) in mice were detected in each group. Based on the metabolomics method, UHPLC-Q-Exactive Orbitrap HRMS method was used; based on principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA), the differentially expressed metabolites (DEMs) were screened using the criteria of variable importance in the projection≥1, fold change of peak area>1 and
P
<0.05; biological analysis was conducted based on databases such as HMDB and PubChem.
RESULTS
2
Compared with CON group, serum levels of
AST, CK, CK-MB and LDH were increased significantly in DOX group (
P
<0.05); compared with DOX group, the serum levels of the above indicators (except for CK-MB) were decreased significantly in GDOX group (
P
<0.05). PCA and OPLS-DA showed that myocardial tissue samples of CON group, DOX group and GDOX group were isolated completely. After database matching, 37 common DEMs were identified, among which 17 DEMs were significantly up-regulated in the DOX group and significantly down-regulated in the GDOX group, and 8 DEMs were significantly down-regulated in the DOX group and significantly up-regulated in the GDOX group; pathway enrichment involved the biosynthesis of unsaturated fatty acids, arachidonic acid metabolism, linoleic acid metabolism, taurine and hypotaurine metabolism; the key metabolites in the above pathways included docosahexaenoic acid, arachidonic acid, phosphatidylcholine (16∶0/18∶3) and taurine.
CONCLUSIONS
2
GA may regulate the biosynthesis of unsaturated fatty acids, arachidonic acid metabolism and other metabolic pathways by acting on the core metabolites such as docosahexaenoic acid and arachidonic acid, thus alleviating the cardiotoxic effects of DOX.
关键词
Keywords
references
KCIUK M , GIELECIŃSKA A , MUJWAR S , et al . Doxorubicin:an agent with multiple mechanisms of anticancer activity [J ] . Cells , 2023 , 12 ( 4 ): 659 .
RAWAT P S , JAISWAL A , KHURANA A , et al . Doxorubicin-induced cardiotoxicity:an update on the molecular mechanism and novel therapeutic strategies for effective management [J ] . Biomedecine Pharmacother , 2021 , 139 : 111708 .
KIM J K , CHOI M S , KIM J Y , et al . Ginkgo biloba leaf extract suppresses intestinal human breast cancer resistance protein expression in mice:correlation with gut microbiota [J ] . Biomedecine Pharmacother , 2021 , 140 : 111712 .
JASIM S T , AL-KURAISHY H M , AL-GAREEB A I . Gingko biloba protects cardiomyocytes against acute doxorubicin induced cardiotoxicity by suppressing oxidative stress [J ] . J Pak Med Assoc , 2019 ,69(Suppl 3)( 8 ): S103 - S107 .
SONG Z J , ZHU X Q , HE Y , et al . Effects of increasing efficacy and decreasing toxicity of ginkgo flavone aglycone on doxorubicin in the treatment of liver cancer [J ] . China Pharm , 2022 , 33 ( 16 ): 1937 - 1942,1949 .
FAZZINI L , CAGGIARI L , DEIDDA M , et al . Metabolomic profiles on antiblastic cardiotoxicity:new perspectives for early diagnosis and cardioprotection [J ] . J Clin Med , 2022 , 11 ( 22 ): 6745 .
WU G S , LI H K , ZHANG W D . Metabolomics and its application in the treatment of coronary heart disease with traditional Chinese medicine [J ] . Chin J Nat Med , 2019 , 17 ( 5 ): 321 - 330 .
SHAO M M , XIANG H J , LU H , et al . Candidate metabolite markers of peripheral neuropathy in Chinese patients with type 2 diabetes [J ] . Am J Transl Res , 2022 , 14 ( 8 ): 5420 - 5440 .
SUN X , ZHU Y M , LI F , et al . Cardioprotective mechanism and active compounds of Folium ginkgo on adriamycin-induced cardiotoxicity:a network pharmaco-logy study [J ] . Comput Math Methods Med , 2022 , 2022 : 4338260 .
CARRASCO R , RAMIREZ M C , NES K , et al . Prevention of doxorubicin-induced cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on docosahexaenoic acid(DHA) and carvedilol direct antioxidant effects:study protocol for a pilot,randomized,double-blind,controlled trial(CarDHA trial) [J ] . Trials , 2020 , 21 ( 1 ): 137 .
ARNOLD W R , DAS A . An emerging pathway of doxorubicin cardiotoxicity mediated through CYP2J2 [J ] . Biochemistry , 2018 , 57 ( 16 ): 2294 - 2296 .
KOLEINI N , NICKEL B E , EDEL A L , et al . Oxidized phospholipids in doxorubicin-induced cardiotoxicity [J ] . Chem Biol Interact , 2019 , 303 : 35 - 39 .
RONG J D , HE T M , ZHANG J Y , et al . Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure [J ] . Lipids Health Dis , 2023 , 22 ( 1 ): 66 .
BARıŞ V Ö , GEDIKLI E , YERSAL N , et al . Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats:echocardiographical and histological findings [J ] . Amino Acids , 2019 , 51 ( 10/11/12 ): 1649 - 1655 .